Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 56,664 | reported | 13 Feb 2026 | tx 148+1,170,028−709,572 |
| aTYR PHARMA INC | 50,000 | reported | 11 May 2026 | tx 3+200,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 12 Feb 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,005 | 0.00 USD | |
| 12 Feb 2026 | TAX_WITHHOLDING | NEUROCRINE BIOSCIENCES INC | 1,082 | 123.10 USD | |
| 13 Feb 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,961 | 0.00 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | NEUROCRINE BIOSCIENCES INC | 1,058 | 124.12 USD | |
| 13 Feb 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,083 | 0.00 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | NEUROCRINE BIOSCIENCES INC | 1,124 | 124.12 USD | |
| 13 Feb 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 16,613 | 0.00 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | NEUROCRINE BIOSCIENCES INC | 8,963 | 124.12 USD | |
| 13 Feb 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 36,287 | 0.00 USD | deriv |
| 12 Feb 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,005 | 0.00 USD | deriv |
| 13 Feb 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,083 | 0.00 USD | deriv |
| 13 Feb 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,961 | 0.00 USD | deriv |
| 13 Feb 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 6,365 | 0.00 USD | deriv |
| 31 Jan 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,294 | 0.00 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | NEUROCRINE BIOSCIENCES INC | 1,292 | 136.06 USD | |
| 31 Jan 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,294 | 0.00 USD | deriv |
| 28 Nov 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 5,970 | 35.99 USD | |
| 28 Nov 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 5,970 | 151.74 USD | |
| 28 Nov 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 5,970 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 13 Feb 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,083 | 0.00 USD | |
| 13 Feb 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 1,056 | 116.71 USD | |
| 13 Feb 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,961 | 0.00 USD | |
| 13 Feb 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 1,098 | 116.74 USD |